These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 15838913

  • 1. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A, Pinna AD.
    Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913
    [Abstract] [Full Text] [Related]

  • 2. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M, Cucchetti A, La Barba G, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD.
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [Abstract] [Full Text] [Related]

  • 3. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti S, Garcia B, Driman DK.
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [Abstract] [Full Text] [Related]

  • 4. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation for patients with hepatocellular carcinoma.
    Ho MC, Wu YM, Hu RH, Ko WJ, Yang PM, Lai MY, Lin MH, Lin HY, Lee PH.
    Transplant Proc; 2004 Oct; 36(8):2291-2. PubMed ID: 15561223
    [Abstract] [Full Text] [Related]

  • 6. Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma.
    Vivarelli M, Dazzi A, Zanello M, Cucchetti A, Cescon M, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD.
    Transplantation; 2010 Jan 27; 89(2):227-31. PubMed ID: 20098287
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
    Zou WL, Zang YJ, Chen XG, Shen ZY.
    Hepatobiliary Pancreat Dis Int; 2008 Apr 27; 7(2):145-51. PubMed ID: 18397848
    [Abstract] [Full Text] [Related]

  • 8. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 27; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 9. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.
    Transplant Proc; 2011 Dec 27; 43(10):3813-8. PubMed ID: 22172852
    [Abstract] [Full Text] [Related]

  • 10. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.
    Am J Gastroenterol; 2005 Dec 27; 100(12):2708-16. PubMed ID: 16393224
    [Abstract] [Full Text] [Related]

  • 11. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A, Berenguer M, Aguilera V, Juan FS, Nicolás D, Pastor M, López-Andujar R, Rayón M, Orbis F, Mora J, De Juan M, Carrasco D, Vila JJ, Prieto M, Berenguer J, Mir J.
    Liver Transpl; 2002 Nov 27; 8(11):1020-7. PubMed ID: 12424715
    [Abstract] [Full Text] [Related]

  • 12. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
    Lee HH, Joh JW, Park JH, Lee KW, Heo JS, Choi SH, Kim SJ, Lee SK.
    Transplant Proc; 2005 Mar 27; 37(2):1251-3. PubMed ID: 15848686
    [Abstract] [Full Text] [Related]

  • 13. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.
    Surgery; 2007 Mar 27; 141(3):330-9. PubMed ID: 17349844
    [Abstract] [Full Text] [Related]

  • 14. Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.
    Pérez-Saborido B, de los Galanes SJ, Menéu-Díaz JC, Romero CJ, Elola-Olaso AM, Suárez YF, Valencia VB, Moreno-González E.
    Transplant Proc; 2007 Sep 27; 39(7):2304-7. PubMed ID: 17889172
    [Abstract] [Full Text] [Related]

  • 15. [Liver transplantation for hepatocellular carcinoma: prognostic analysis of 89 cases].
    Zheng SS, Xu X, Liang TB, Wang WL, Shen Y, Zhang M, Wu J, Lu AW, Shao ZX.
    Zhonghua Wai Ke Za Zhi; 2005 Apr 01; 43(7):450-4. PubMed ID: 15854372
    [Abstract] [Full Text] [Related]

  • 16. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma.
    Kneteman NM, Oberholzer J, Al Saghier M, Meeberg GA, Blitz M, Ma MM, Wong WW, Gutfreund K, Mason AL, Jewell LD, Shapiro AM, Bain VG, Bigam DL.
    Liver Transpl; 2004 Oct 01; 10(10):1301-11. PubMed ID: 15376305
    [Abstract] [Full Text] [Related]

  • 17. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
    Park UJ, Kim YH, Kang KJ, Lim TJ.
    Korean J Hepatol; 2008 Sep 01; 14(3):371-80. PubMed ID: 18815460
    [Abstract] [Full Text] [Related]

  • 18. Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma.
    Rodríguez-Perálvarez M, Tsochatzis E, Naveas MC, Pieri G, García-Caparrós C, O'Beirne J, Poyato-González A, Ferrín-Sánchez G, Montero-Álvarez JL, Patch D, Thorburn D, Briceño J, De la Mata M, Burroughs AK.
    J Hepatol; 2013 Dec 01; 59(6):1193-9. PubMed ID: 23867318
    [Abstract] [Full Text] [Related]

  • 19. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S, Lee SG, Joh JW, Suh KS, Kim DG.
    Liver Transpl; 2005 Oct 01; 11(10):1265-72. PubMed ID: 16184545
    [Abstract] [Full Text] [Related]

  • 20. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, Kim IH, Yi NJ, Lee KU.
    Surgery; 2007 May 01; 141(5):598-609. PubMed ID: 17462459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.